These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9213617)

  • 1. Interests and policies of the state of Sarawak, Malaysia regarding intellectual property rights for plant derived drugs.
    Chung FJ
    J Ethnopharmacol; 1996 Apr; 51(1-3):201-4. PubMed ID: 9213617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanzania's policy on biodiversity prospecting and drug discovery programs.
    Mahunnah RL; Mshigeni KE
    J Ethnopharmacol; 1996 Apr; 51(1-3):221-8. PubMed ID: 9213620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal plant genetic resources and international cooperation: the Brazilian perspective.
    Elisabetsky E; Costa-Campos L
    J Ethnopharmacol; 1996 Apr; 51(1-3):111-9; discussion 119-20. PubMed ID: 9213607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodiversity prospecting in Nigeria: seeking equity and reciprocity in intellectual property rights through partnership arrangements and capacity building.
    Iwu MM
    J Ethnopharmacol; 1996 Apr; 51(1-3):209-19. PubMed ID: 9213619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juridical and sociocultural problems on the definition of a law concerning property, usage and access to genetic resources in Colombia.
    Calle R
    J Ethnopharmacol; 1996 Apr; 51(1-3):127-42; discussion 142-6. PubMed ID: 9213609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The position of intellectual property rights in drug discovery and development from natural products.
    Boyd MR
    J Ethnopharmacol; 1996 Apr; 51(1-3):17-25; discussion 25-7. PubMed ID: 9213613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research, valorization and exploitation of biological resources for medicinal purposes in the Malagasy Republic (Madagascar).
    Randimbivololona F
    J Ethnopharmacol; 1996 Apr; 51(1-3):195-200. PubMed ID: 9213616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual Property Rights, Naturally Derived Bioactive Compounds and Resource Conservation. Proceedings of the American Society of Pharmacognosy interim annual meeting. San Jose, Costa Rica, October 20-22, 1994.
    J Ethnopharmacol; 1996 Apr; 51(1-3):ix-xi, 1-330. PubMed ID: 9213605
    [No Abstract]   [Full Text] [Related]  

  • 9. Rules and regulations on the collection in Cameroon of biological materials for biological testing and drug discovery.
    Jato JG; Simon JE; Symonds P; Koufani A; Njamnshi AB
    J Ethnopharmacol; 1996 Apr; 51(1-3):121-5. PubMed ID: 9213608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rules and regulations of the Government of Vietnam on collection and exportation of biological materials.
    Mai TV; Tran KC
    J Ethnopharmacol; 1996 Apr; 51(1-3):173-6. PubMed ID: 9213614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging challenges for sustainable development and forest conservation in Sarawak, Borneo.
    Alamgir M; Campbell MJ; Sloan S; Engert J; Word J; Laurance WF
    PLoS One; 2020; 15(3):e0229614. PubMed ID: 32126070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal issues in sharing the benefits of biodiversity prospecting.
    Mays TD; Mazan KD
    J Ethnopharmacol; 1996 Apr; 51(1-3):93-102; discussion 102-9. PubMed ID: 9213633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Earth's vanishing medicine cabinet: rain forest destruction and its impact on the pharmaceutical industry.
    Newman EB
    Am J Law Med; 1994; 20(4):479-501. PubMed ID: 7618640
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological diversity, indigenous knowledge, drug discovery and intellectual property rights: creating reciprocity and maintaining relationships.
    King SR; Carlson TJ; Moran K
    J Ethnopharmacol; 1996 Apr; 51(1-3):45-57. PubMed ID: 9213630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 16. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
    Baker BK
    PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intellectual property rights and traditional medicine: policy dilemmas at the interface.
    Timmermans K
    Soc Sci Med; 2003 Aug; 57(4):745-56. PubMed ID: 12821021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management policy and utilization of botanical resources in the Dominican Republic].
    Garcia R; Roersch C
    J Ethnopharmacol; 1996 Apr; 51(1-3):147-60. PubMed ID: 9213610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of civil society in protecting public health over commercial interests: lessons from Thailand.
    Ford N; Wilson D; Bunjumnong O; von Schoen Angerer T
    Lancet; 2004 Feb; 363(9408):560-3. PubMed ID: 14975620
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intellectual property rights in Costa Rica in the light of the Biodiversity Convention].
    Salazar R; Cabrera JA
    J Ethnopharmacol; 1996 Apr; 51(1-3):177-93. PubMed ID: 9213615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.